MANP: a novel particulate guanylyl cyclase A receptor/cGMP activator for resistant hypertension: preliminary first in human clinical trial results. Issue 1 (December 2015) - Burnett, John; McKie, Paul; Heublein, Denise; Huntley, Brenda; Chen, Horng; Cannone, Valentina; Buglioni, Alessia; McCormick, Daniel